Physician profile
Philip Levy
NPI 1700902053
$8,887.76
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,480 · 2020: $252 · 2021: $2,728 · 2022: $428.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $3,567.71 | 2019-2022 | |
| Novo Nordisk INC | $2,467.45 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $424.42 | 2019-2022 | |
| Mannkind Corporation | $351.28 | 2019-2021 | |
| Lilly USA, LLC | $283.04 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $214.16 | 2019-2022 | |
| Insulet Corporation | $152.56 | 2019-2022 | |
| Abbvie INC. | $133.47 | 2019-2020 | |
| Amarin Pharma, INC. | $131.93 | 2019 | |
| Merck Sharp & Dohme LLC | $129.73 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $122.57 | 2019 | |
| Abbott Laboratories | $109.43 | 2019-2022 | |
| Shire North American Group INC | $85.40 | 2019 | |
| Amgen INC. | $77.94 | 2019-2021 | |
| Regeneron Pharmaceuticals, INC. | $71.61 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $59.46 | 2020-2022 | |
| Radius Health, INC. | $53.07 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $51.91 | 2019 | |
| Dexcom, INC. | $50.63 | 2021-2022 | |
| Lifescan, INC. | $44.75 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $43.64 | 2019 | |
| Medtronic Minimed, INC. | $37.60 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.87 | 2020 | |
| Xeris Pharmaceuticals, INC. | $19.03 | 2021 | |
| Endo Pharmaceuticals INC. | $17.92 | 2019 | |
| Tandem Diabetes Care, INC. | $17.60 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.74 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $15.96 | 2021 | |
| Grt US Holding, INC. | $15.42 | 2022 | |
| Antares Pharma, INC. | $14.64 | 2019 | |
| Allergan, INC. | $14.17 | 2019 | |
| Jazz Pharmaceuticals INC. | $13.10 | 2021 | |
| Vistapharm, INC. | $13.03 | 2021 | |
| Companion Medical, INC. | $12.60 | 2020 | |
| Apria Healthcare LLC | $11.93 | 2021 | |
| Aytu Biopharma, INC. | $11.48 | 2019 | |
| Vivus LLC | $9.51 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.